secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001641172-25-002779
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences extends CEO Mattacchione's resignation to April 30, 2025
--------------------------------------------------------------------------------

- CEO Robert Mattacchione's resignation effective date extended from March 31 to no later than April 30, 2025.
- Extension is to allow time for efficient transition of CEO position.
- Mattacchione intends to remain Chairman of the Board and Chairman of subsidiary Novo Healthnet after CEO departure.
- Resignation is not due to any disagreement with company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000164117225002779/0001641172-25-002779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000164117225002779/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer